1. Home
  2. CYCC vs AVGR Comparison

CYCC vs AVGR Comparison

Compare CYCC & AVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • AVGR
  • Stock Information
  • Founded
  • CYCC 1992
  • AVGR 2007
  • Country
  • CYCC United States
  • AVGR United States
  • Employees
  • CYCC N/A
  • AVGR N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • AVGR Medical/Dental Instruments
  • Sector
  • CYCC Health Care
  • AVGR Health Care
  • Exchange
  • CYCC Nasdaq
  • AVGR Nasdaq
  • Market Cap
  • CYCC 2.3M
  • AVGR 2.0M
  • IPO Year
  • CYCC N/A
  • AVGR 2015
  • Fundamental
  • Price
  • CYCC $0.34
  • AVGR $0.49
  • Analyst Decision
  • CYCC Buy
  • AVGR Strong Buy
  • Analyst Count
  • CYCC 2
  • AVGR 1
  • Target Price
  • CYCC $11.00
  • AVGR $5.00
  • AVG Volume (30 Days)
  • CYCC 431.0K
  • AVGR 194.1K
  • Earning Date
  • CYCC 11-12-2024
  • AVGR 11-07-2024
  • Dividend Yield
  • CYCC N/A
  • AVGR N/A
  • EPS Growth
  • CYCC N/A
  • AVGR N/A
  • EPS
  • CYCC N/A
  • AVGR N/A
  • Revenue
  • CYCC $74,000.00
  • AVGR $7,262,000.00
  • Revenue This Year
  • CYCC N/A
  • AVGR N/A
  • Revenue Next Year
  • CYCC $88.68
  • AVGR $93.49
  • P/E Ratio
  • CYCC N/A
  • AVGR N/A
  • Revenue Growth
  • CYCC N/A
  • AVGR N/A
  • 52 Week Low
  • CYCC $0.32
  • AVGR $0.39
  • 52 Week High
  • CYCC $4.00
  • AVGR $5.45
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 37.88
  • AVGR 22.72
  • Support Level
  • CYCC $0.33
  • AVGR $0.42
  • Resistance Level
  • CYCC $0.42
  • AVGR $0.73
  • Average True Range (ATR)
  • CYCC 0.04
  • AVGR 0.09
  • MACD
  • CYCC 0.01
  • AVGR -0.03
  • Stochastic Oscillator
  • CYCC 8.21
  • AVGR 21.80

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

About AVGR Avinger Inc.

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

Share on Social Networks: